Cellev8, a leading provider of Superoxide Dismutase (SOD) gummies, and Zyppah, the innovator of patented anti-snoring devices, have joined forces in a groundbreaking collaborative sales agreement.

Zyppah is the creator of FDA-cleared, clinically proven anti-snoring devices. With a 91% success rate in clinical trials, Zyppah's patented tongue stabilization technology has helped nearly a million ...

CALABASAS, Calif., Nov. 20, 2018 /PRNewswire/ -- ZYPPAH, a company dedicated to improving the sleep health of everyone in the bedroom, today announced that NBA Legend and TV Personality, Shaquille ...

New Jersey, United States, Dec 09, 2022 /DigitalJournal/ Anti-snoring devices are devices designed to help reduce or eliminate snoring. Typically worn at night while sleeping, they are designed to ...

Limited-edition pink Zyppah devices aim to raise $50,000 for breast cancer awareness and research by October 31. This campaign is more than raising funds-it's about honoring those we've lost, standing ...

Cellev8 and Zyppah Announce Collaborative Sales Agreement Targeting 90 Million Snoring Americans. WELLINGTON, FL / ACCESSWIRE / October 29, 2024 / Cellev8 and Zyppah Announce Collaborative Sales ...

The impact of snoring-related inflammation can lead to various health issues: Increased risk of cardiovascular diseases, diabetes, and neurodegenerative conditions. Higher levels of C-reactive protein ...